Celltrion Healthcare receives Health Canada marketing authorization for world's first subcutaneous formulation of infliximab, Remsima SC, for the treatment of people with rheumatoid arthritis

1 February 2021 - This novel formulation provides an alternative administration option for Canadian physicians and their patients. ...

Read more →

Health Canada approves Imbruvica (ibrutinib) plus rituximab for the treatment of patients with chronic lymphocytic leukaemia

13 January 2021 - Patients aged 70 or younger with previously untreated CLL lived longer without disease progression compared to patients ...

Read more →

Health Canada approves Onureg (azacitidine tablets), first maintenance therapy for patients in remission from acute myeloid leukaemia

12 January 2021 - Onureg has shown clinically meaningful increase in overall survival for patients. ...

Read more →

Health Canada approves Lundbeck's Vyepti (eptinezumab)--the first and only intravenous preventive treatment for migraine

12 January 2021 - Lundbeck is pleased to announce that Vyepti (eptinezumab) has been approved by Health Canada for the preventive ...

Read more →

Health Canada approves Bavencio for the maintenance treatment of patients with advanced bladder cancer

11 January 2021 - Bavencio is the first and only maintenance therapy for unresectable locally advanced or metastatic urothelial carcinoma ...

Read more →

KYE Pharmaceuticals announces approval of Corzyna in Canada (ranolazine extended release tablets)

5 January 2020 - KYE Pharmaceuticals today announced an important milestone, Corzyna (ranolazine extended release tablets) has now been approved by ...

Read more →

Canada approves the Moderna vaccine, paving the way for inoculations in its vast far north

23 December 2020 - Canada’s regulator approved Moderna’s vaccine on Wednesday, a move that will make it easier to inoculate ...

Read more →

Health Canada approves ALK's Ragwitek sublingual allergy immunotherapy tablets for paediatric patients with ragweed allergy

22 December 2020 - With the indication expanded to paediatric patients, ALK Canada now provides adults and children a SLIT tablet ...

Read more →

Janssen announces Health Canada approval of Darzalex combination regimen for newly diagnosed, transplant eligible patients with multiple myeloma

22 December 2020 - Data show Darzalex in combination with bortezomib, thalidomide and dexamethasone before and after autologous stem cell transplant ...

Read more →

Health Canada approves expanded indication for Soliqua

18 December 2020 - New indication for Soliqua offers an alternative approach for Canadians living with type 2 diabetes requiring treatment ...

Read more →

Sandoz Canada receives authorisation from Health Canada to launch new biosimilar Hyrimoz (adalimumab)

17 December 2020 - Hyrimoz approved for use in all same indications as reference medicine* including rheumatology, gastro-enterology and dermatology. ...

Read more →

Health Canada approves Zolgensma, the one-time gene therapy for paediatric patients with spinal muscular atrophy

16 December 2020 - Zolgensma is designed to address the genetic root cause of SMA by replacing the missing or defective ...

Read more →

Health Canada approves Venclexta (venetoclax) in combination with azacitidine or low dose cytarabine for untreated acute myeloid leukaemia

15 December 2020 - Health Canada's approval of Venclexta for newly diagnosed AML patients who are ineligible for intensive chemotherapy is ...

Read more →

Valeo Pharma announces Health Canada approval for Redesca and Redesca Hp

9 December 2020 - Valeo Pharma announced today that Health Canada has issued a Notice of Compliance for Redesca and ...

Read more →

Canada health regulator approves Pfizer's COVID-19 vaccine

10 December 2020 - Canada’s health regulator has approved Pfizer’s COVID-19 vaccine. ...

Read more →